VANI Vivani Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: VANI

Price (delayed)

$1.78

Market cap

$97.86M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.5

Enterprise value

$96.56M

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in ...

Highlights
Vivani Medical's net income has shrunk by 85% YoY but it has increased by 4.7% QoQ
The company's quick ratio fell by 44% YoY but it rose by 9% QoQ
The equity has plunged by 53% YoY and by 21% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Peers: NVRO OFIX NURO

Key stats

What are the main financial stats of VANI
Market
Shares outstanding
54.98M
Market cap
$97.86M
Enterprise value
$96.56M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.37
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$25.65M
EBITDA
-$24.39M
Free cash flow
-$24.59M
Per share
EPS
-$0.5
Free cash flow per share
-$0.48
Book value per share
$0.41
Revenue per share
$0
TBVPS
$0.9
Balance sheet
Total assets
$45.8M
Total liabilities
$25.04M
Debt
$20.7M
Equity
$20.76M
Working capital
$17.34M
Liquidity
Debt to equity
1
Current ratio
4.03
Quick ratio
3.84
Net debt/EBITDA
0.05
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-50.5%
Return on equity
-87.2%
Return on invested capital
-85.7%
Return on capital employed
-64%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VANI stock price

How has the Vivani Medical stock price performed over time
Intraday
3.49%
1 week
9.2%
1 month
-12.53%
1 year
22.76%
YTD
74.51%
QTD
-3.78%

Financial performance

How have Vivani Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$26.97M
Net income
-$25.65M
Gross margin
N/A
Net margin
N/A
Vivani Medical's net income has shrunk by 85% YoY but it has increased by 4.7% QoQ
VANI's operating income is down by 27% YoY but it is up by 6% QoQ

Growth

What is Vivani Medical's growth rate over time

Valuation

What is Vivani Medical stock price valuation
P/E
N/A
P/B
4.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is down by 39% year-on-year but it is up by 11% since the previous quarter
VANI's price to book (P/B) is 130% more than its last 4 quarters average of 1.9 but 39% less than its 5-year quarterly average of 7.2
The equity has plunged by 53% YoY and by 21% from the previous quarter

Efficiency

How efficient is Vivani Medical business performance
The return on assets has dropped by 121% year-on-year but it has increased by 2.1% since the previous quarter
Vivani Medical's return on invested capital has surged by 79% YoY and by 36% QoQ
The return on equity has declined by 14% since the previous quarter

Dividends

What is VANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VANI.

Financial health

How did Vivani Medical financials performed over time
The total assets is 83% more than the total liabilities
The company's quick ratio fell by 44% YoY but it rose by 9% QoQ
Vivani Medical's current ratio has decreased by 42% YoY and by 2.4% QoQ
The equity has plunged by 53% YoY and by 21% from the previous quarter
VANI's debt to equity is up by 25% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.